İNKAYA, A. Ç. Et Al. 2019. Role of Tumor Necrosis Factor alpha promoter polymorphisms in interferon related side effects in chronic hepatitis B patients under interferon alpha 2b treatment. Acta Medica , vol.50, no.2 , 32-38.

İNKAYA, A. Ç., TÜRK ARIBAŞ, E., KANDEMİR, B., Acar, H., & BİTİRGEN, M., (2019). Role of Tumor Necrosis Factor alpha promoter polymorphisms in interferon related side effects in chronic hepatitis B patients under interferon alpha 2b treatment. Acta Medica , vol.50, no.2, 32-38.

İNKAYA, AHMET Et Al. "Role of Tumor Necrosis Factor alpha promoter polymorphisms in interferon related side effects in chronic hepatitis B patients under interferon alpha 2b treatment," Acta Medica , vol.50, no.2, 32-38, 2019

İNKAYA, AHMET Ç. Et Al. "Role of Tumor Necrosis Factor alpha promoter polymorphisms in interferon related side effects in chronic hepatitis B patients under interferon alpha 2b treatment." Acta Medica , vol.50, no.2, pp.32-38, 2019

İNKAYA, A. Ç. Et Al. (2019) . "Role of Tumor Necrosis Factor alpha promoter polymorphisms in interferon related side effects in chronic hepatitis B patients under interferon alpha 2b treatment." Acta Medica , vol.50, no.2, pp.32-38.

@article{article, author={AHMET ÇAĞKAN İNKAYA Et Al. }, title={Role of Tumor Necrosis Factor alpha promoter polymorphisms in interferon related side effects in chronic hepatitis B patients under interferon alpha 2b treatment}, journal={Acta Medica}, year=2019, pages={32-38} }